Ascend Advanced Therapies, a leading gene to GMP development partner, has announced significant investments to expand its global infrastructure.   The company’s flagship facility in Alachua, Florida, is undergoing a major expansion to include GMP suite capacity up to 500L scales and new fill/finish capabilities. Additionally, the Munich, Germany facility is bolstering its GMP quality control (QC) testing, analytical, and process development capacity to meet increasing industry demand. Th...